Company: PCRX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001396814-25-000041
Chunk: 281

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 281
---
 A. Reinhart, III.***10-Q10.18/4/201610.24Non-Healthcare Professional Consulting Agreement, effective October 1, 2024, by and between Pacira Pharmaceuticals, Inc. and Charles. A. Reinhart, III*     ***10-Q10.511/6/202410.25Amended and Restated Executive Employment Agreement, dated as of November 4, 2024, by and between Pacira Pharmaceuticals, Inc. and Lauren Riker.***8-K10.411/6/202410.26Form of Indemnification Agreement between the Registrant and its directors and officers.***10-K10.222/29/202410.27Commercial Outsourcing Services Agreement entered into as of February 26, 2024 by the Registrant and Integrated Commercialization Solutions, Inc.††10-K10.232/29/202410.28Pacira BioSciences, Inc. Deferred Compensation Plan.***8-K10.16/11/202010.29Amendment No. 1 to Pacira BioSciences, Inc. Deferred Compensation Plan.***10-K10.252/28/202310.30Amendment No. 2 to Pacira BioSciences, Inc. Deferred Compensation Plan.*     ***10.31Pacira BioSciences, Inc. Long-Term Incentive Plan.*     ***10.32Strategic Co-Production Agreement dated April 4, 2014,by and between Pacira Pharmaceuticals, Inc. and Patheon UK Limited.†10-Q10.17/31/201410.33Manufacturing and Supply Agreement dated April 4, 2014,by and between Pacira Pharmaceuticals, Inc. and Patheon UK Limited.†10-Q10.27/31/201410.34First Amendment to Manufacturing and Supply Agreement dated April 2, 2019 by and between Pacira Limited and Patheon UK Limited.*   ††   ##10.35Second Amendment to Manufacturing and Supply Agreement dated October 31, 2024 by and between Pacira Limited and Patheon UK Limited.*   ††   ##10.36Technical Transfer and Service Agreement dated April 4, 2014, by and between by and between Pacira Pharmaceuticals, Inc. and Patheon UK Limited.†10-Q10.37/31/201410.37First Amendment to Technical Transfer and Service Agreement dated